- Profile
- Personal Information
- Publications
Experts in Clinical Sciences
Natasha Anandaraj Mark White Susan K Birden MICHAEL BILL Pravir Kumar Roger Badia P.Madhava Soma Sundaram Douglas K. Martin Blaine Y. Takesue Karsten Rebner JEFF ANDERSON Syed Umarhathab R.Sivakumar Enanalap Periyar Amy Berkov Kristin Meyer Nora Stelter A.J.R. Albert Heck Simon Allison BIG ANNA MARIA View MoreEREZ CHIMOVITS
SENIOR MANAGING DIRECTOR, ORBIMED ISRAEL
Pharma
Ato Bio
Israel
Mr. Chimovits is a Managing Director. Erez has 14 years of operational experience, including 10 years of senior managerial experience in public companies. Prior to joining OrbiMed Erez was the CEO of NasVax (TASE: NSVX). NasVax acquired Protea and struck agreements with GlaxoSmithKline and Novartis. Previously, Erez spent more than seven years with Compugen (Nasdaq:CGEN), as President, Compugen USA Inc. and Executive VP, Commercial Operations. At Compugen, he had P&L responsibility for more than 100 people and led multiple transactions including J&J, Novartis, Teva, Abbott, Medarex and others. In addition to Atox Bio, Erez is a board member at AdicetBio, FutuRx, LogicBio, Emendo, Novus, Nucleix, NovellusDX, BiomX and Mitoconix.  Erez earned his M.B.A., M.Sc. in Microbiology and his B.Sc. from Tel Aviv University.
Healthcare